Katherine W Cook

6PUBLICATIONS
6CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 28, 2024
Modi-2 a vaccine stimulating CD4 responses to homocitrullinated self epitopes as therapy for solid cancers.

Abdullah A Al-Omari, Katherine W Cook, Peter Symonds

|Oct 19, 2023
Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.

Sabaria Shah, Katherine W Cook, Peter Symonds

|Feb 10, 2022
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.

Ruhul H Choudhury, Peter Symonds, Samantha J Paston

|Jul 29, 2021
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.

Katherine W Cook, Wei Xue, Peter Symonds

|May 10, 2019
T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy.

Victoria A Brentville, Peter Symonds, Katherine W Cook

|Mar 24, 2018
Current Strategies to Enhance Anti-Tumour Immunity.

Katherine W Cook, Lindy G Durrant, Victoria A Brentville

Pageof 1

Frequent Collaborators

3 joint publications

Victoria A Brentville

2 joint publications

Ruhul H Choudhury

1 joint publications

Ian Daniels

1 joint publications

Mohamed Gijon